Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.

Saved in:
Bibliographic Details
Title: Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.
Authors: Nishimori S; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Biochemistry, Teikyo University School of Medicine, Tokyo, Japan., O'Meara MJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Castro CD; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Noda H; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Chugai Pharmaceutical Co., Tokyo, Japan., Cetinbas M; Department of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., da Silva Martins J; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ayturk U; Musculoskeletal Integrity Program, Hospital for Special Surgery, New York, New York, USA., Brooks DJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Bruce M; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nagata M; Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA., Ono W; Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA., Janton CJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bouxsein ML; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Foretz M; Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France., Berdeaux R; Department of Integrative Biology and Pharmacology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas, USA., Sadreyev RI; Department of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gardella TJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jüppner H; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kronenberg HM; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wein MN; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2019 Dec 02; Vol. 129 (12), pp. 5187-5203.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI130126